184P A phase I study of the cancer-specific vaccine FMPV-1 in healthy male subjects to assess safety and immune response. (December 2022) - Singh, N.; Miller, R.M.; Arbe-Barnes, S.J.; Kvalheim Eriksen, H.; Inderberg, E.M.; Iverson, B.; Eriksen, J.A.